These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 21458518)
41. Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs. Bidgood TL; Papich MG J Vet Pharmacol Ther; 2005 Aug; 28(4):329-41. PubMed ID: 16050812 [TBL] [Abstract][Full Text] [Related]
42. Serum concentrations and pharmacokinetics of enrofloxacin after intravenous and intragastric administration to mares. Haines GR; Brown MP; Gronwall RR; Merritt KA Can J Vet Res; 2000 Jul; 64(3):171-7. PubMed ID: 10935883 [TBL] [Abstract][Full Text] [Related]
43. [Pharmacokinetics of baytril (enrofloxacin) in dogs]. Küng K; Wanner M Schweiz Arch Tierheilkd; 1994; 136(10):329-34. PubMed ID: 7801085 [TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics and tissue distribution of enrofloxacin and its metabolite ciprofloxacin in the Chinese mitten-handed crab, Eriocheir sinensis. Wu G; Meng Y; Zhu X; Huang C Anal Biochem; 2006 Nov; 358(1):25-30. PubMed ID: 16962551 [TBL] [Abstract][Full Text] [Related]
45. Mutation rate of avian intestinal coliform bacteria when pressured with fluoroquinolones. Medders WM; Wooley RE; Gibbs PS; Shotts EB; Brown J Avian Dis; 1998; 42(1):146-53. PubMed ID: 9533092 [TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics of difloxacin in healthy and E. coli-infected broiler chickens. Abo El-Ela FI; Radi AM; El-Banna HA; El-Gendy AA; Tohamy MA Br Poult Sci; 2014; 55(6):830-6. PubMed ID: 25229385 [TBL] [Abstract][Full Text] [Related]
47. Comparative pharmacokinetics of enrofloxacin and ciprofloxacin in lactating dairy cows and beef steers following intravenous administration of enrofloxacin. Idowu OR; Peggins JO; Cullison R; Bredow Jv Res Vet Sci; 2010 Oct; 89(2):230-5. PubMed ID: 20129633 [TBL] [Abstract][Full Text] [Related]
48. Influence of Escherichia coli endotoxin-induced endotoxaemia on the pharmacokinetics of enrofloxacin after intravenous administration in rabbits. Elmas M; Yazar E; Uney K; Er Karabacak A J Vet Med A Physiol Pathol Clin Med; 2006 Oct; 53(8):410-4. PubMed ID: 16970630 [TBL] [Abstract][Full Text] [Related]
49. Determination and kinetics of enrofloxacin and ciprofloxacin in Tra catfish (Pangasianodon hypophthalmus) and giant freshwater prawn (Macrobrachium rosenbergii) using a liquid chromatography/mass spectrometry method. Danyi S; Widart J; Douny C; Dang PK; Baiwir D; Wang N; Tu HT; Tung VT; Phuong NT; Kestemont P; Scippo ML J Vet Pharmacol Ther; 2011 Apr; 34(2):142-52. PubMed ID: 21395605 [TBL] [Abstract][Full Text] [Related]
50. Concentration of enrofloxacin and its metabolite ciprofloxacin in canine matrices of the locomotor system. Ehinger AM; Meyer-Lindenberg A; Vick M; Nolte I; Kietzmann M J Vet Med A Physiol Pathol Clin Med; 2002 Mar; 49(2):99-104. PubMed ID: 11958474 [TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetics of enrofloxacin following intravenous administration to greater rheas: a preliminary study. de Lucas JJ; Rodríguez C; Martella MB; Lábaque MC; Navarro JL; San Andrés MI Res Vet Sci; 2005 Jun; 78(3):265-7. PubMed ID: 15766947 [TBL] [Abstract][Full Text] [Related]
52. Resistance to non-quinolone antimicrobials in commensal Escherichia coli isolates from chickens treated orally with enrofloxacin. Jurado S; Medina A; de la Fuente R; Ruiz-Santa-Quiteria JA; Orden JA Jpn J Vet Res; 2015 Nov; 63(4):195-200. PubMed ID: 26753246 [TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetic behaviour of enrofloxacin in greater rheas following a single-dose intramuscular administration. de Lucas JJ; Navarro JL; Rubio S; Vignolo PE; Asis VC; González F; Rodríguez C Vet J; 2008 Jan; 175(1):136-8. PubMed ID: 17303451 [TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetic properties of enrofloxacin in rabbits. Broome RL; Brooks DL; Babish JG; Copeland DD; Conzelman GM Am J Vet Res; 1991 Nov; 52(11):1835-41. PubMed ID: 1664673 [TBL] [Abstract][Full Text] [Related]
55. A pharmacokinetic study of enrofloxacin and its active metabolite ciprofloxacin after oral and intramuscular dosing of enrofloxacin in rhesus monkeys (Macaca mulatta). Klein H; Hasselschwert D; Handt L; Kastello M J Med Primatol; 2008 Aug; 37(4):177-83. PubMed ID: 18384536 [TBL] [Abstract][Full Text] [Related]
56. Intramuscular and oral disposition of enrofloxacin in African grey parrots following single and multiple doses. Flammer K; Aucoin DP; Whitt DA J Vet Pharmacol Ther; 1991 Dec; 14(4):359-66. PubMed ID: 1663561 [TBL] [Abstract][Full Text] [Related]
57. Bioavailability of enrofloxacin after oral administration to fed and fasted pigs. Nielsen P; Gyrd-Hansen N Pharmacol Toxicol; 1997 May; 80(5):246-50. PubMed ID: 9181604 [TBL] [Abstract][Full Text] [Related]
58. Impact of aflatoxin B1 on the pharmacokinetic disposition of enrofloxacin in broiler chickens. Kalpana S; Srinivasa Rao G; Malik JK Environ Toxicol Pharmacol; 2015 Sep; 40(2):645-9. PubMed ID: 26363987 [TBL] [Abstract][Full Text] [Related]
59. Effect of Multi Drug Resistance Protein 4 (MRP4) Inhibition on the Pharmacokinetics and Pharmacodynamics of Ciprofloxacin in Normal and Rats with LPS-Induced Inflammation. Prasad VG; Achanta S; Tammineni YR; Alla GR; Thirtham MR; Rao GS Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):733-741. PubMed ID: 26458556 [TBL] [Abstract][Full Text] [Related]
60. Plasma and tissue pharmacokinetics of marbofloxacin in experimentally infected chickens with Mycoplasma gallisepticum and Escherichia coli. Ding H; Wang L; Shen X; Gu X; Zeng D; Zeng Z J Vet Pharmacol Ther; 2013 Oct; 36(5):511-5. PubMed ID: 23550715 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]